widespread
concern
potenti
new
pandem
influenza
avian
origin
increas
report
avian
influenza
affect
bird
human
across
multipl
contin
pandem
plan
focus
part
adult
older
children
influenza
uncommon
ill
newborn
infant
would
seem
time
review
clinic
featur
manag
influenza
newborn
paper
also
review
epidemiolog
influenza
newborn
infant
antivir
therapi
vaccin
control
measur
neonat
intens
care
unit
event
outbreak
rariti
influenza
popul
lack
control
trial
therapi
necess
mean
recommend
base
larg
upon
level
evid
influenza
rna
viru
orthomyxovirida
famili
classifi
type
b
c
type
affect
mani
anim
speci
respons
clinic
infect
human
type
b
respons
nonpandem
influenza
human
wherea
type
c
caus
mild
coryz
ill
influenza
nomenclatur
subdivid
basi
surfac
glycoprotein
hemagglutinin
h
neuraminidas
n
exampl
least
hemagglutinin
nine
neuraminidas
describ
antigen
distinct
glycoprotein
major
virul
factor
hemagglutinin
mediat
viral
bind
cell
receptor
wherea
neuraminidas
crucial
role
releas
viru
cell
follow
viral
replic
minor
chang
surfac
antigen
antigen
drift
contribut
season
epidem
influenza
wherea
major
chang
antigen
shift
associ
pandem
three
pandem
influenza
centuri
recent
occur
develop
modern
neonat
intens
care
descript
effect
pandem
newborn
infant
clear
howev
pandem
associ
increas
neonat
postneonat
infant
mortal
well
increas
preterm
deliveri
recent
time
outbreak
influenza
describ
neonat
intens
care
unit
sometim
coincid
communitywid
epidem
furthermor
recent
avian
influenza
diseas
particularli
sever
infant
young
children
transmiss
influenza
date
almost
entir
owe
direct
acquisit
bird
fear
chang
viral
genom
potenti
genet
mix
coinfect
human
influenza
strain
could
make
human
human
transmiss
possibl
therebi
set
scene
rapid
spread
within
popul
next
pandem
arriv
like
newborn
infant
expos
develop
clinic
ill
influenza
signific
caus
pediatr
hospit
admiss
highest
attack
rate
preschool
school
age
children
classic
clinic
featur
includ
high
fever
myalgia
headach
malais
wherea
small
proport
sign
pulmonari
involv
comparison
influenza
uncommon
infect
first
month
life
gener
mild
symptom
commun
studi
studi
infant
epidem
found
high
proport
infect
asymptomat
infant
manifest
symptom
commonli
describ
abrupt
onset
high
fever
symptom
upper
respiratori
tract
infect
clinic
featur
may
indistinguish
bacteri
sepsi
milder
ill
infant
newborn
attribut
transplacent
acquisit
protect
antibodi
provid
protect
month
birth
well
protect
breast
milk
howev
epidem
pandem
influenza
associ
signific
mortal
infant
influenzarel
pediatr
death
report
us
influenza
season
highest
pediatr
mortal
rate
infant
less
month
old
sever
influenza
describ
small
number
newborn
infant
figur
glezen
et
al
describ
dayoldterm
infant
die
suddenli
pneumon
presum
relat
influenza
infant
mother
develop
influenza
day
postpartum
infant
detect
antibodi
epidem
viru
cord
serum
gestat
twin
die
epidem
describ
cunney
et
al
influenza
virusassoci
hemophagocyt
syndrom
van
den
dungen
et
al
describ
gestat
infant
becam
unwel
respiratori
ill
day
life
viral
cultur
grew
influenza
b
develop
signific
lung
injuri
neurolog
complic
subsequ
die
epidem
influenza
neonat
intens
care
unit
part
reason
influenza
uncommon
newborn
period
presum
relat
reduc
contact
neonat
gener
unwel
adult
children
howev
sever
descript
nosocomi
spread
influenza
within
neonat
unit
outbreak
usual
coincid
epidem
influenza
within
broader
commun
although
case
difficult
pinpoint
sourc
largest
outbreak
infant
admit
two
neonat
unit
spain
posit
influenza
viru
cunney
et
al
describ
similar
outbreak
involv
infant
level
iii
nurseri
canada
instanc
major
newborn
asymptomat
furthermor
except
one
preterm
infant
symptomat
newborn
recov
complet
mechan
ventil
twin
pregnanc
gestat
age
birth
weight
identifi
risk
factor
infect
antivir
agent
newborn
infant
number
differ
antivir
therapi
use
treatment
influenza
children
howev
infant
limit
evid
either
safeti
efficaci
agent
none
neuraminidas
inhibitor
licens
use
young
children
either
europ
usa
similarli
studi
demonstr
safeti
antivir
therapi
influenza
pregnanc
breastfeed
use
potenti
benefit
mother
outweigh
possibl
risk
fetu
infant
ribavirin
nucleosid
analog
vitro
activ
influenza
b
main
use
treatment
respiratori
syncyti
viru
rsv
infect
ribavirin
usual
administ
inhal
given
intraven
infus
latter
describ
adult
sever
influenza
young
child
influenza
cardiomyopathi
ribavirin
teratogen
make
inhal
administr
problemat
owe
potenti
staff
exposur
amantadin
rimantadin
inhibit
replic
influenza
act
viral
protein
activ
influenza
b
use
year
prophylaxi
treatment
influenza
infect
resist
may
develop
rapidli
addit
associ
revers
central
figur
influenza
pneumon
gestat
preterm
infant
becam
unwel
day
life
chest
xray
day
admiss
influenza
nicu
dj
wilkinson
et
al
nervou
system
side
effect
random
placebocontrol
trial
either
agent
treatment
influenza
children
effect
possibl
pandem
strain
eg
amantadin
rimantadin
shown
teratogen
high
dose
anim
studi
use
pregnant
women
breastfeed
recent
develop
agent
neuraminidas
inhibitor
oseltamivir
zanamavir
effect
influenza
b
shown
reduc
durat
ill
previous
healthi
children
adult
also
associ
less
advers
event
inhibitor
treatment
agent
must
start
within
h
onset
symptom
effect
prophylaxi
neuraminidas
inhibitor
inhibitor
effect
adult
prevent
influenza
start
within
h
exposur
studi
children
zanamavir
oseltamivir
cross
placenta
excret
breast
milk
anim
found
teratogen
safeti
human
pregnanc
breastfeed
establish
specif
safeti
concern
use
neuraminidas
inhibitor
infant
rais
releas
us
food
drug
administr
anim
trial
oseltamivir
sevendayold
rat
fed
mgkg
oseltamivir
time
dose
recommend
children
treatment
led
death
mani
rat
brain
level
time
higher
adult
anim
expos
dose
clinic
relev
unclear
howev
led
recommend
neuraminidas
inhibitor
use
infant
nevertheless
japan
rate
encephalopathi
influenza
childhood
high
mani
children
infant
treat
oseltamivir
two
case
seri
total
infant
younger
year
treat
oseltamivir
found
associ
oseltamivir
use
mortal
encephalopathi
limit
factor
use
antivir
agent
critic
ill
neonat
relat
method
administr
zanamavir
ribavirin
usual
administ
inhal
oseltamavir
amantadin
rimantadin
administ
oral
suspens
avail
intraven
prepar
ribavirin
influenza
vaccin
primari
mean
prevent
influenza
commun
shown
safe
effect
prevent
signific
ill
adult
children
inactiv
live
attenu
form
avail
inactiv
influenza
vaccin
approv
use
infant
older
month
routin
recommend
us
although
current
europ
australia
infant
age
month
vaccin
thought
immunogen
infant
less
month
live
attenu
vaccin
recommend
children
younger
year
vaccin
safe
throughout
pregnanc
breastfeed
influenza
infect
pregnanc
associ
increas
morbid
consequ
influenza
vaccin
recommend
women
pregnant
influenza
season
addit
vaccin
may
provid
protect
neonat
first
month
life
current
vaccin
grown
initi
embryon
hen
egg
consequ
risk
hypersensit
reaction
individu
sever
egg
allergi
candid
pandem
vaccin
develop
shown
safe
immunogen
howev
efficaci
data
date
given
lack
proven
safe
treatment
influenza
neonat
prevent
spread
infect
may
effect
measur
context
epidem
pandem
tabl
influenza
viru
primarili
spread
person
person
respiratori
droplet
consequ
cohort
isol
affect
infant
recommend
author
rel
import
airborn
droplet
nuclei
spread
unclear
gener
neg
pressur
isol
requir
nosocomi
rsv
epidem
pediatr
intens
care
unit
droplet
tabl
key
measur
event
outbreak
influenza
screen
patient
use
rapid
diagnost
test
enabl
cohort
presymptomat
asymptomat
infant
affect
infant
cohort
droplet
precaut
taken
minim
spread
infant
admit
home
unit
isol
screen
test
result
avail
staff
parent
immun
staff
parent
unwel
enter
unit
sent
home
antivir
prophylaxi
provid
staff
parent
unvaccin
infect
occur
strain
cover
vaccin
dj
wilkinson
et
al
precaut
import
physic
barrier
influenza
surviv
varieti
fomit
environ
although
clinic
signific
direct
contact
spread
unclear
good
handwash
like
reduc
transmiss
time
diagnosi
essenti
effect
cohort
tradit
method
detect
includ
immunofluoresc
rapid
diagnost
test
use
immunoassay
viral
neuraminidas
detect
use
rapid
diagnost
test
influenza
enabl
detect
cohort
infect
infant
associ
reduc
nosocomi
transmiss
pediatr
hospit
detect
viral
rna
polymeras
chain
reaction
pcr
sensit
techniqu
recent
develop
realtim
pcr
led
becom
method
choic
rapid
reliabl
diagnosi
influenza
avoid
exposur
infant
influenza
staff
recommend
work
unwel
howev
complianc
medic
nurs
staff
histor
poor
measur
reduc
spread
unknown
benefit
exampl
applic
viral
filter
expiratori
arm
ventil
circuit
describ
neonat
set
context
outbreak
sever
acut
respiratori
syndrom
sar
may
use
ventil
infant
influenza
one
aforement
neonat
intens
care
outbreak
procedur
chang
ventil
tube
alter
order
reduc
aerosol
spread
immun
prevent
transmiss
influenza
vulner
popul
recommend
healthcar
worker
immun
annual
influenza
complianc
rate
amongst
staff
neonat
unit
elsewher
hospit
low
routin
immun
parent
highrisk
infant
neonat
unit
addit
pregnant
mother
also
advoc
unclear
much
protect
vaccin
provid
event
novel
strain
epidem
prophylact
treatment
antivir
agent
unimmun
parent
staff
suggest
author
adjunct
immun
replac
report
experi
inhibitor
amantadin
use
describ
two
larger
neonat
intens
care
outbreak
remain
seen
whether
neuraminidas
inhibitor
effect
better
toler
like
newborn
infant
affect
set
new
pandem
influenza
mortal
rate
previou
outbreak
within
neonat
unit
surprisingli
low
howev
pandem
influenza
may
well
sever
popul
lack
antibodi
protect
novel
strain
although
antivir
agent
shown
effect
children
adult
agent
proven
efficaci
safeti
infant
avail
formul
limit
use
preterm
infant
may
lead
difficult
decis
whether
use
unproven
therapi
context
lifethreaten
ill
agent
use
parent
inform
limit
evid
provid
inform
consent
care
followup
may
provid
use
inform
futur
infant
import
measur
neonat
intens
care
unit
event
pandem
like
prevent
one
tabl
effect
vaccin
avail
staff
parent
immun
antivir
prophylaxi
staff
parent
even
newborn
may
role
although
despit
stockpil
avail
agent
pandem
may
well
limit
isol
affect
infant
strict
adher
infectioncontrol
precaut
critic
control
spread
within
unit
